Arena Pharmaceuticals Inc (NASDAQ:ARNA)

47.32
Delayed Data
As of Oct 14
 +0.16 / +0.34%
Today’s Change
31.97
Today|||52-Week Range
64.48
+21.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues38.3M124.0M21.3M18.0M
 
 
 
 
 
Cost of Goods Sold3.1M6.0M----
 
 
 
Depreciation And Amortization10.0M9.4M4.3M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income25.2M108.6M----
 
 
 
General Expenses124.4M97.7M97.1M159.0M
 
 
 
 
 
Research And Development88.4M66.4M71.0M115.0M
 
 
 
 
 
Total Operating Expenses137.6M113.0M101.3M162.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-99.2M11.0M-80.0M-144.8M
 
 
 
 
 
Extraordinary Credit474.0K0.00--0.00
 
 
Extraordinary Charge-4.0M-28.1M-12.0M0.00
 
 
 
 
Interest Expense On Debt6.8M6.5M6.1M5.7M
 
 
 
 
 
Other Expenses1.4M472.0K1.7M2.9M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-108.0M-22.9M-95.9M-138.8M
 
 
 
 
 
Income Taxes0.000.000.00-110.3M
 
 
Minority Interest0.00-380.0K-1.3M0.00
 
 
 
Discontinued Operations0.000.003.1M-1.6M
 
 
 
Extraordinary Items0.000.000.00725.0K
 
 
Net Income-108.0M-22.5M-91.4M-30.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.1M24.3M33.0M47.0M
 
 
 
 
 
Shares To Calculate EPS Diluted24.1M24.3M33.0M47.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.50-$0.90-$2.77-$0.63
 
 
 
 
 
EPS Diluted-$4.50-$0.90-$2.77-$0.64